Ketamine for
OCD in Baltimore
When SSRIs and ERP haven't broken the loop — a different circuit, a different mechanism
Ketamine for OCD Baltimore costs $499.99 per session ($375 for Vitality Circle members) and is an off-label IV infusion evaluated for obsessive-compulsive disorder that hasn't responded adequately to SRIs and ERP therapy. OCD is driven by dysfunction of the cortico-striato-thalamo-cortical (CSTC) circuit, a glutamate-driven feedback loop — ketamine's NMDA blockade targets that glutamatergic hyperactivity directly, where SSRIs reach it only indirectly. The evidence is promising but small and mixed: in the 2013 Rodriguez randomized crossover trial, obsessions eased within hours of a single infusion, but durability remains the open question, so ketamine is positioned to complement ERP — never replace it. Every infusion is delivered as anesthesiologist-led care, under the medical direction of Dr. Brijen Joshi MD, a Johns Hopkins anesthesiologist, with a Certified Registered Nurse Anesthetist (CRNA) on-site. Self-pay with an itemized superbill you can file with your insurance; not everyone is a candidate, and you'll be told clearly.
"The team is extremely professional, compassionate and knowledgeable — they take the time to explain the process thoroughly and care about your well-being throughout." — Google review, Vita Nova patient
Founder & Medical Director, Vita Nova · Johns Hopkins Faculty Physician · Assistant Professor, Anesthesiology & Critical Care Medicine · Chief, Thoracic Anesthesia, Johns Hopkins Hospital · Board-Certified Anesthesiologist
Mon–Fri: 1PM–8PM · Sat: 10AM–2PM
513 Bayview Blvd, Canton, Baltimore MD 21224
(443) 563-1059
Tell Us About Your Situation
Answer a few quick questions — our clinical team reaches out within 1 business day to discuss whether ketamine therapy may be right for you.
Your information is confidential. A clinical team member follows up within 1 business day.
What Is OCD — And Why It's a Circuit Problem
Obsessive-compulsive disorder is characterized by recurrent, intrusive obsessions — unwanted thoughts, images, or urges that cause significant distress — and repetitive compulsions performed to reduce that distress. The compulsion provides short-term relief but reinforces the cycle, making the next obsession more likely and more distressing.
OCD is not a monoamine disorder in the way depression is. It is fundamentally a circuit disorder — specifically, a dysfunction of the cortico-striato-thalamo-cortical (CSTC) loop. This is why SSRIs provide only partial relief for many OCD patients: they are acting on the wrong primary neurotransmitter system. The dominant neurotransmitter in the CSTC circuit is glutamate — which is where ketamine's mechanism becomes directly relevant.
Generates obsessive thought · Signals "something is wrong"
Fails to filter excessive OFC signals · Passes urgency forward
Receives amplified signal · Generates compulsion to neutralize
Amplifies signal · Sends it back to cortex · Loop continues
OCD Subtypes Evaluated at Vita Nova
OCD presents across several distinct subtypes — all four major presentations are evaluated for ketamine at Vita Nova when first-line treatments have not produced adequate relief.
ERP & SSRIs First — Ketamine When They Haven't Been Enough
Ketamine for OCD is evaluated at Vita Nova only for patients who have already attempted first-line treatments. ERP and SSRIs are the gold standard — with the strongest evidence bases. If you have not yet tried these, they should be your first step.
The gold-standard psychotherapy for OCD. Involves graduated exposure to feared situations while preventing the compulsive response. An adequate course means approximately 12–20 structured sessions with a trained ERP therapist.
FDA-approved SSRIs for OCD include fluoxetine, fluvoxamine, paroxetine, sertraline, and the TCA clomipramine. OCD typically requires higher SSRI doses than depression and a trial of at least 8–12 weeks at therapeutic dose.
The Mechanism — Glutamate, NMDA & the CSTC Loop
OCD is the condition for which the glutamate hypothesis is the primary neurobiological model. The dominance of glutamate in CSTC circuit dysfunction makes NMDA blockade mechanistically more directly relevant to OCD than to almost any other mental-health condition ketamine is evaluated for.
- Modulate serotonin reuptake — serotonin has indirect modulatory effects on the CSTC circuit but is not the primary driver
- Require 8–12 weeks at therapeutic dose before OCD response can be assessed — often at doses higher than used for depression
- 40–60% of OCD patients achieve inadequate relief even after adequate SSRI trial
- Do not directly address glutamatergic hyperactivity in orbitofrontal-striatal-thalamic circuits
- Blocks NMDA glutamate receptors in the orbitofrontal cortex, striatum, and thalamic circuits — the primary nodes of CSTC hyperactivity in OCD
- Rapidly reduces glutamatergic hyperactivity in the CSTC loop — potentially interrupting the pathological feedback that generates obsessions
- In the Rodriguez et al. 2013 RCT, significant OCD symptom reduction (Y-BOCS score) was observed within hours of a single infusion
- Mechanism is distinct from SSRIs — explaining why it may be effective in patients for whom SSRI treatment has failed
References: Rodriguez CI et al. (2013). Randomized controlled crossover trial of ketamine in OCD: proof-of-concept. Neuropsychopharmacology 38:2475–2483. PMID 23783065. · Rodriguez CI et al. (2016). Can exposure-based CBT extend the effects of IV ketamine in OCD? Open-label trial. PMID 27046314. · Pittenger C et al. (2011). Glutamate abnormalities in obsessive-compulsive disorder: neurobiology, pathophysiology, and treatment. Review.
The Research Behind Ketamine for OCD
The evidence base for ketamine in OCD is anchored in one small double-blind crossover trial — rigorous by design but far smaller than the treatment-resistant depression evidence base, with mixed follow-up results and durability unresolved. The glutamate hypothesis is well-established. Larger trials are ongoing.
Ketamine for OCD — Cost at Vita Nova Baltimore
Ketamine for OCD is off-label. Ketamine at Vita Nova is self-pay — you pay directly, and we provide an itemized superbill you can file with your insurance. HSA and FSA cards are accepted for the full cost, and a member plan brings the per-session rate down.
| Treatment | Non-Member | Vitality Circle Member | Saving |
|---|---|---|---|
| Ketamine Infusion — per session Off-Label | $499.99 | $375 | save $124.99 |
| Complete Series — 6 infusions | $2,849.94 | $2,250 | +3 complimentary hydration IVs |
Self-pay, with a superbill. Vita Nova is self-pay for ketamine. We provide an itemized superbill you can file with your insurance. HSA and FSA accepted; Community Heroes discounts available. Pricing August 2026 — subject to change. Full pricing guide →
Complementary Treatments Alongside Ketamine for OCD
Chronic OCD is physiologically taxing — sustained hyperarousal and the metabolic cost of compulsive behaviors deplete nutritional reserves. Vitality Circle members receive significant discounts on all wellness services.
Magnesium is a natural NMDA receptor modulator — directly relevant to ketamine's mechanism in the CSTC circuit. Magnesium deficiency is associated with increased NMDA receptor sensitivity and heightened anxiety. IM delivery achieves reliable bioavailability independent of GI absorption.
✅ Included for Vitality Circle members (2 shots/month)NAD+ supports cellular energy and neurological function. The sustained metabolic demand of OCD — constant hyperarousal, compulsive activity, sleep disruption — depletes NAD+ reserves. IV delivery supports neurological restoration alongside ketamine's circuit-level mechanism.
Members: 25% off all dosesChronic anxiety and OCD deplete B-vitamin reserves — particularly B1, B6, and B5. Long-term SSRI use is also associated with B12 depletion. IM delivery achieves immediate bioavailability of the full B spectrum for nervous system support.
✅ Included for Vitality Circle members (2 shots/month)Iron-deficiency anemia causes fatigue, brain fog, and restlessness that can amplify the exhaustion of living with chronic OCD. Iron is also a cofactor in dopamine and serotonin synthesis. Iron IV does not treat OCD — but when bloodwork confirms deficiency, correcting it restores reserves faster than oral iron.
Members: 25% offVitamin D3 deficiency is associated with anxiety, mood disorders, and neurological function impairment. Baltimore's northern latitude makes seasonal deficiency common — particularly relevant for OCD patients whose avoidance behaviors may limit outdoor time.
✅ Included for Vitality Circle members (2 shots/month)Clinical note: These wellness services are not treatments for OCD and are not part of Vita Nova's ketamine clinical protocols. ERP therapy should be continued alongside any ketamine pathway — the IOCDF therapist directory at iocdf.org can help identify OCD-specialist ERP therapists in Maryland.
Special Pricing for Those Who Serve
OCD affects approximately 2–3% of the population — but its prevalence is higher in occupational groups with high stress, perfectionism demands, and responsibility burdens. The Community Heroes program ensures cost is not the determining factor.
OCD & Ketamine — Questions Answered
Common questions from patients evaluating ketamine therapy for OCD in Baltimore.
When SSRIs & ERP
Haven't Broken the Loop —
A mechanism that targets the glutamatergic CSTC circuit directly — where SSRIs don't reach. Evaluated for patients with documented SSRI and ERP treatment history, and anesthesiologist-led, under the medical direction of Dr. Brijen Joshi MD, with a CRNA on-site. ERP therapy continues alongside ketamine. Self-pay with an itemized superbill you can file with your insurance.
Canonical URL: https://vitanovawellnessclinic.com/ketamine-ocd-baltimore/ · Last reviewed August 2026
Medically reviewed by Dr. Brijen L. Joshi MD — Assistant Professor of Anesthesiology & Critical Care Medicine, Johns Hopkins University School of Medicine · Chief of Thoracic Anesthesia, Johns Hopkins Hospital · Medical Director, Vita Nova Ketamine & Wellness Clinic. · View full team →
